ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip (NASDAQ: BIOS) today announced that the Company will present at two investor conferences in September.
- Monday, September 19, 2011 at 12:00 pm EDT - At the UBS Global Life Sciences Conference, to be held September 19-21, 2011, at the Grand Hyatt New York in New York City. Richard M. Smith, President and Chief Executive Officer, and MJ Graves, interim Chief Financial Officer and Treasurer will present. The presentation will also be available via a live audio webcast at the following link: http://cc.talkpoint.com/ubsx001/091911a_im/?entity=112_JWS1BPQ
- Tuesday, September 27, 2011 at 2:30 pm EDT - At the Sixth Annual JMP Securities Healthcare Conference, to be held September 27-28, 2011, at the St. Regis in New York City. Richard M. Smith and MJ Graves will present. The presentation will also be available via a live audio webcast at the following link: http://wsw.com/webcast/jmp14/bios/
Following each presentation, a replay will be available through BioScrip's website at www.bioscrip.com under the "Investors" section and will remain available for two weeks after the actual presentation date.
About BioScrip
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national provider of specialty pharmacy and home health services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications and home health services. Our services are designed to improve clinical outcomes with chronic and acute healthcare conditions while controlling overall healthcare costs.